We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Hemostemix is an autologous stem cell therapy company, founded in 2003. A winner of the World Economic Forum Technology Pioneer Award, the Company has 87 patents on the derivation of angiogenic cell precursors (ACP-01), neuronal cell precursors (NCP-01) and cardiomyocyte cell precursors (CCP-01) fro... Hemostemix is an autologous stem cell therapy company, founded in 2003. A winner of the World Economic Forum Technology Pioneer Award, the Company has 87 patents on the derivation of angiogenic cell precursors (ACP-01), neuronal cell precursors (NCP-01) and cardiomyocyte cell precursors (CCP-01) from a synergetic cell population that is sourced from the patient's blood. The Company is selling exempt compassionate treatments to individuals afflicted with critical limb ischemia, for example, and conducting clinical trials to commercialize its lead product, ACP-01, for the treatment of critical limb ischemia and peripheral arterial disease, and heart disease (ischemic cardiomyopathy, dilated cardiomyopathy). Show more
While most stock indices are in the red today, shares of this pioneering stem cell firm are soaring following this morning's news of an LOI. In a press release this morning, Hemostemix Inc To read...
HEMOSTEMIX ANNOUNCES CLOSING OF UNIT PRIVATE PLACEMENT May 10, 2021, Calgary, Alberta -- InvestorsHub NewsWire -- Hemostemix Inc...
Hemostemix Announces Completion of Phase II Clinical Trial Subject Follow Up & HMTXF Up-list Calgary, Alberta, April 23, 2021-- InvestorsHub NewsWire -- Hemostemix Inc. ("Hemostemix" or the...
Hemostemix Announces a $2,500,000 Lead Order and its Clinical Trial and Litigation Updates Calgary, Alberta, April 12, 2021-- InvestorsHub NewHemostemix Inc...
Hemostemix Annonces it is Trading on the Frankfurt Stock Exchange and it has Retained HE Capital Markets LTD. Calgary, Alberta, April 8, 2021 -- InvestorsHub NewsWire...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.0016 | 2.91438979964 | 0.0549 | 0.0565 | 0.0549 | 3000 | 0.0549 | CS |
4 | 0.0242 | 74.9226006192 | 0.0323 | 0.0725 | 0.0323 | 9091 | 0.07028415 | CS |
12 | 0.0055 | 10.7843137255 | 0.051 | 0.078 | 0.0323 | 33118 | 0.0548215 | CS |
26 | 0.0227 | 67.1597633136 | 0.0338 | 0.079 | 0.024 | 22286 | 0.05030043 | CS |
52 | 0.0025 | 4.62962962963 | 0.054 | 0.079 | 0.024 | 17858 | 0.05015611 | CS |
156 | -0.08042 | -58.7350277534 | 0.13692 | 0.3279 | 0.024 | 20712 | 0.13673529 | CS |
260 | 0.0465 | 465 | 0.01 | 0.4372 | 0.0049 | 34558 | 0.08243878 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions